Dr. Sara I Pai, MD, PhD - Massachusetts General Hospital/Harvard Medical School - Director, Translational Research in Head and Neck Cancer

Dr. Sara I Pai

MD, PhD

Massachusetts General Hospital/Harvard Medical School

Director, Translational Research in Head and Neck Cancer

Boston, MASSACHUSETTS | United States

Main Specialties: Otolaryngology

Additional Specialties: Otolaryngology-Head and Neck Surgery


Top Author

Dr. Sara I Pai, MD, PhD - Massachusetts General Hospital/Harvard Medical School - Director, Translational Research in Head and Neck Cancer

Dr. Sara I Pai

MD, PhD

Introduction

Primary Affiliation: Massachusetts General Hospital/Harvard Medical School - Boston, MASSACHUSETTS , United States

Specialties:

Additional Specialties:

Research Interests:

Metrics

Number of Publications

74

Publications

Number of Profile Views

1043

Profile Views

Number of Article Reads

1307

Reads

Number of PubMed Central Citations

1054

PubMed Central Citations

Education

Jul 2007
Johns Hopkins Hospital
Residency
Jul 2003
Johns Hopkins Hospital
Internship
May 2002
Johns Hopkins School of Medicine
MD/PhD

Top co-authors

William H Westra
William H Westra

Department of Pathology

19
Chien-fu Hung
Chien-fu Hung

The Johns Hopkins University

15
Ralph P Tufano
Ralph P Tufano

Johns Hopkins University School of Medicine

12
T-C Wu
11
Justin A Bishop
Justin A Bishop

Department of Pathology

9
John R Saunders
John R Saunders

Jr. Head and Neck Center

9
Shiwen Peng
Shiwen Peng

Department of Pathology

8
Patrick K Ha
Patrick K Ha

Johns Hopkins University School of Medicine

7
Simon R Best
Simon R Best

Johns Hopkins School of Medicine

7
Takenori Ogawa
Takenori Ogawa

Tohoku University School of Medicine

6

Publications

74Publications

1307Reads

1054PubMed Central Citations

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.

Genome Med 2018 07 20;10(1):54. Epub 2018 Jul 20.

Department of Molecular and Cell Biology, Goldman School of Dental Medicine, Boston University School of Medicine, 72 East Concord Street, E4, Boston, MA, 02118, USA.

View Article
July 2018
29 Reads
4.940 Impact Factor

PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma.

Endocr Pathol 2018 Mar;29(1):59-67

Department of Pathology, Massachusetts General Hospital, Warren 219, 55 Fruit Street, Boston, MA, 02114, USA.

View Article
March 2018
23 Reads
1.640 Impact Factor

HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.

Oral Oncol 2018 Feb 28;77:92-97. Epub 2017 Dec 28.

Otolaryngology-Head and Neck Surgery, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address:

View Article
February 2018
15 Reads
3.610 Impact Factor

Programmed cell death ligand 1 as a biomarker in head and neck cancer.

Cancer Cytopathol 2017 Jul 4;125(7):529-533. Epub 2017 May 4.

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article
July 2017
11 Reads
3.350 Impact Factor

Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.

Laryngoscope 2017 06 1;127(6):1334-1338. Epub 2017 Feb 1.

Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.

View Article
June 2017
13 Reads
2.030 Impact Factor

High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.

Mol Cancer Res 2017 02 29;15(2):179-188. Epub 2016 Nov 29.

Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.

View Article
February 2017
26 Reads
4 PubMed Central Citations(source)
4.380 Impact Factor

Successful Treatment of an Aggressive Tracheal Malignancy With Immunotherapy.

Ann Thorac Surg 2017 Feb;103(2):e123-e125

Department of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article
February 2017
14 Reads
3.850 Impact Factor

The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.

Oral Oncol 2016 10 5;61:152-8. Epub 2016 Aug 5.

Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, MD, United States; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.

View Article
October 2016
13 Reads
8 PubMed Central Citations(source)
3.610 Impact Factor

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Int J Cancer 2016 08 22;139(3):510-7. Epub 2016 Mar 22.

International Agency for Research on Cancer, 69372 Lyon cedex 08, France.

View Article
August 2016
24 Reads
5 PubMed Central Citations(source)
5.080 Impact Factor

In-situ tumor vaccination: Bringing the fight to the tumor.

Hum Vaccin Immunother 2015 ;11(8):1901-9

a OncoSec Medical Inc. ; San Diego , CA USA.

View Article
May 2016
13 Reads
14 PubMed Central Citations(source)
2.130 Impact Factor

Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes.

Cancer Immunol Immunother 2016 Mar 13;65(3):261-71. Epub 2016 Jan 13.

Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

View Article
March 2016
27 Reads
2 PubMed Central Citations(source)
3.940 Impact Factor

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.

PLoS One 2015 5;10(1):e116389. Epub 2015 Jan 5.

Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, United States of America.

View Article
January 2016
17 Reads
6 PubMed Central Citations(source)
3.230 Impact Factor

Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.

Oral Oncol 2015 Aug 18;51(8):751-8. Epub 2015 Jun 18.

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, United States.

View Article
August 2015
23 Reads
9 PubMed Central Citations(source)
3.610 Impact Factor

A staged thyroidectomy approach for gastric bypass patients.

Laryngoscope 2015 Apr 18;125(4):1028-30. Epub 2014 Jul 18.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.

View Article
April 2015
11 Reads
2.030 Impact Factor

Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis.

Ann Otol Rhinol Laryngol 2015 Feb 13;124(2):110-5. Epub 2014 Aug 13.

Johns Hopkins School of Medicine, Baltimore, Maryland, USA

View Article
February 2015
15 Reads
1 PubMed Central Citation(source)
1.050 Impact Factor

Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.

J Clin Oncol 2014 Aug 28;32(23):2408-15. Epub 2014 Apr 28.

Gypsyamber D'Souza, Shirani Rajan, and Jennifer Gerber, Johns Hopkins Bloomberg School of Public Health; Sara I. Pai, Johns Hopkins Medical Institutions, Baltimore, MD; Neil D. Gross, Oregon Health and Science University, Portland, OR; Robert Haddad, Dana-Farber Cancer Institute, Boston, MA; Karen S. Anderson, Arizona State University, Tempe, AZ; Maura L. Gillison, Ohio State University Comprehensive Cancer Center, Columbus, OH; and Marshall R. Posner, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article
August 2014
17 Reads
26 PubMed Central Citations(source)
18.430 Impact Factor

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay.

Oral Oncol 2014 Jun 12;50(6):600-4. Epub 2014 Mar 12.

Department of Otolaryngology - Head and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore, MD 21287, United States; Department of Oncology, The Johns Hopkins School of Medicine, Baltimore, MD 21287, United States. Electronic address:

View Article
June 2014
38 Reads
4 PubMed Central Citations(source)
3.610 Impact Factor

PET/CT in the management of thyroid cancers.

AJR Am J Roentgenol 2014 Jun;202(6):1316-29

1 Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.

View Article
June 2014
19 Reads
7 PubMed Central Citations(source)
2.730 Impact Factor

The impact of molecular testing on the surgical management of patients with thyroid nodules.

Ann Surg Oncol 2014 Jun 13;21(6):1862-9. Epub 2014 Feb 13.

Endocrine Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article
June 2014
13 Reads
3 PubMed Central Citations(source)
3.930 Impact Factor

Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

J Acquir Immune Defic Syndr 2014 Apr;65(5):603-10

*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, MI; ‡Department of Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX; §Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA; ‖Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY; ¶Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI; #Department of Otolaryngology/Head and Neck Surgery, Johns Hopkins University, Baltimore, MD; **Cancer Biology Program, University of Michigan, Ann Arbor, MI; ††Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, TX; §§Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA; and ‖‖Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

View Article
April 2014
14 Reads
18 PubMed Central Citations(source)
4.560 Impact Factor

Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors.

Clin Cancer Res 2014 Feb 3;20(3):644-57. Epub 2013 Dec 3.

Authors' Affiliations: Departments of Pathology, Obstetrics and Gynecology, Molecular Microbiology and Immunology, Oncology, and Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions; Department of Biostatistics and Bioinformatics, Sidney Kimmel Cancer Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland; Departments of Obstetrics and Gynecology, Kunming Medical University, Yunnan, China; Nephrology, Chang-Gung Memorial Hospital, Gueishan; Department of Obstetrics and Gynecology, Tri-Service General Hospital, Taipei, Taiwan; and Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.

View Article
February 2014
14 Reads
16 PubMed Central Citations(source)
8.720 Impact Factor

The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma.

Surgery 2013 Dec;154(6):1272-80; discussion 1280-2

Division of Head and Neck Endocrine Surgery, Department of Otolaryngology Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.

View Article
December 2013
15 Reads
4 PubMed Central Citations(source)
3.380 Impact Factor

Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.

Cancer 2013 Oct 16;119(19):3462-71. Epub 2013 Jul 16.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article
October 2013
19 Reads
12 PubMed Central Citations(source)
4.890 Impact Factor

Mission impossible: how HPV-associated head and neck cancers escape a primed immune response.

Authors:
Sara I Pai

Oral Oncol 2013 Aug 1;49(8):723-5. Epub 2013 May 1.

View Article
August 2013
13 Reads
1 PubMed Central Citation(source)
3.610 Impact Factor

Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract.

Am J Surg Pathol 2013 Jun;37(6):836-44

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

View Article
June 2013
11 Reads
18 PubMed Central Citations(source)
5.140 Impact Factor

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma.

Authors:
Sara I Pai

Oncoimmunology 2013 May;2(5):e24065

Department of Otolaryngology-Head and Neck Surgery; Johns Hopkins University School of Medicine; Baltimore, MD USA ; Department of Oncology; Johns Hopkins University School of Medicine; Baltimore, MD USA.

View Article
May 2013
10 Reads
2 PubMed Central Citations(source)
6.280 Impact Factor

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

Cancer Res 2013 Mar 3;73(6):1733-41. Epub 2013 Jan 3.

Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.

View Article
March 2013
39 Reads
160 PubMed Central Citations(source)
9.330 Impact Factor

Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.

Oral Oncol 2013 Mar 10;49(3):244-8. Epub 2012 Oct 10.

Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

View Article
March 2013
14 Reads
4 PubMed Central Citations(source)
3.610 Impact Factor

Human papillomavirus-related carcinomas of the sinonasal tract.

Am J Surg Pathol 2013 Feb;37(2):185-92

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

View Article
February 2013
15 Reads
33 PubMed Central Citations(source)
5.140 Impact Factor

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.

Cancer Immunol Immunother 2013 Jan 4;62(1):171-82. Epub 2012 Aug 4.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

View Article
January 2013
15 Reads
25 PubMed Central Citations(source)
3.940 Impact Factor

Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer.

Head Neck 2012 Oct 3;34(10):1418-21. Epub 2011 Nov 3.

Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article
October 2012
20 Reads
2 PubMed Central Citations(source)
2.640 Impact Factor

Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.

Otolaryngol Clin North Am 2012 Aug;45(4):807-22

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, 601 North Caroline Street, JHOC 6th floor, Baltimore, MD 21287, USA.

View Article
August 2012
11 Reads
6 PubMed Central Citations(source)
1.340 Impact Factor

HPV-associated head and neck cancers.

Authors:
Sara I Pai

Otolaryngol Clin North Am 2012 Aug 16;45(4):xi-xii. Epub 2012 May 16.

View Article
August 2012
14 Reads
1.340 Impact Factor

Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.

Cancer Cytopathol 2012 Feb 12;120(1):18-25. Epub 2011 Jul 12.

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231-2410, USA.

View Article
February 2012
12 Reads
8 PubMed Central Citations(source)
3.350 Impact Factor

Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration.

World J Surg 2012 Jan;36(1):69-74

Department of Oncologic Surgery/Head and Neck Surgery CEPON, R. Presidente Coutinho, 579, Sala 304, Florianopolis, SC 88015-231, Brazil.

View Article
January 2012
12 Reads
10 PubMed Central Citations(source)
2.640 Impact Factor

HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Am J Surg Pathol 2012 Jan;36(1):142-8

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article
January 2012
12 Reads
12 PubMed Central Citations(source)
5.140 Impact Factor

Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma.

Head Neck 2011 Dec 18;33(12):1727-34. Epub 2011 Jan 18.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institution, Baltimore, Maryland, USA.

View Article
December 2011
13 Reads
6 PubMed Central Citations(source)
2.640 Impact Factor

Profile of patients with completion thyroidectomy and assessment of their suitability for outpatient surgery.

Otolaryngol Head Neck Surg 2011 Nov 22;145(5):727-31. Epub 2011 Aug 22.

Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

View Article
November 2011
28 Reads
1 PubMed Central Citation(source)
1.720 Impact Factor

Tumor size and presence of calcifications on ultrasonography are pre-operative predictors of lymph node metastases in patients with papillary thyroid cancer.

J Surg Oncol 2011 Nov 8;104(6):613-6. Epub 2011 Jul 8.

Endocrine Surgery Section, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

View Article
November 2011
37 Reads
5 PubMed Central Citations(source)
3.240 Impact Factor

Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.

Int J Oncol 2011 Aug 23;39(2):337-44. Epub 2011 May 23.

Department of Otolaryngology, Head and Neck Surgery, The Johns Hopkins University, 1550 Orleans Street, CRBII (Rm 574), Baltimore, MD 21231, USA.

View Article
August 2011
12 Reads
7 PubMed Central Citations(source)
3.020 Impact Factor

Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.

J Biomed Sci 2010 Jul 26;17:61. Epub 2010 Jul 26.

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

View Article
July 2010
11 Reads
3 PubMed Central Citations(source)
2.740 Impact Factor

Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity.

Cancer Res 2010 Apr;70(8):3062-70

Divison of Infection and Immunology, Graduate School of Medicine, Korea University, Seoul, South Korea.

View Article
April 2010
18 Reads
11 PubMed Central Citations(source)
9.330 Impact Factor

Thyroid and parathyroid surgery. Preface.

Otolaryngol Clin North Am 2010 Apr;43(2):xiii-xiv

Division of Head and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.

View Article
April 2010
12 Reads
1.340 Impact Factor

Reoperation for recurrent/persistent well-differentiated thyroid cancer.

Otolaryngol Clin North Am 2010 Apr;43(2):353-63, ix

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MA 21287, USA.

View Article
April 2010
14 Reads
3 PubMed Central Citations(source)
1.340 Impact Factor

Characterization of human papillomavirus type 11-specific immune responses in a preclinical model.

Laryngoscope 2010 Mar;120(3):504-10

Department of Otolaryngology-Head and Neck Surgery, Baltimore, Maryland 21287, USA.

View Article
March 2010
12 Reads
5 PubMed Central Citations(source)
2.030 Impact Factor

Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma.

Otolaryngol Head Neck Surg 2009 Dec;141(6):737-42

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, and the Johns Hopkins Head and Neck Surgery, Baltimore, MD 21231, USA.

View Article
December 2009
19 Reads
4 PubMed Central Citations(source)
1.720 Impact Factor

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.

Vaccine 2009 Sep 19;27(40):5450-9. Epub 2009 Jul 19.

Department of Otolaryngology/Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article
September 2009
14 Reads
50 PubMed Central Citations(source)
3.620 Impact Factor

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Laryngoscope 2009 Aug;119(8):1542-9

Department of Otolaryngology/Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

View Article
August 2009
13 Reads
25 PubMed Central Citations(source)
2.030 Impact Factor

Combination of viral oncolysis and tumor-specific immunity to control established tumors.

Clin Cancer Res 2009 Jul 7;15(14):4581-8. Epub 2009 Jul 7.

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

View Article
July 2009
13 Reads
8 PubMed Central Citations(source)
8.720 Impact Factor

Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.

Annu Rev Pathol 2009 ;4:49-70

Departments of Otolarygology, Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

View Article
May 2009
10 Reads
82 PubMed Central Citations(source)
18.750 Impact Factor

Femtosecond laser treatment enhances DNA transfection efficiency in vivo.

J Biomed Sci 2009 Apr 1;16:36. Epub 2009 Apr 1.

Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD 21218, USA.

View Article
April 2009
13 Reads
5 PubMed Central Citations(source)
2.740 Impact Factor

Activation of Akt as a mechanism for tumor immune evasion.

Mol Ther 2009 Mar 23;17(3):439-47. Epub 2008 Dec 23.

Divison of Infection and Immunology, Graduate School of Medicine, Korea University, Seoul, South Korea.

View Article
March 2009
11 Reads
31 PubMed Central Citations(source)
6.230 Impact Factor

Central compartment neck dissection for thyroid cancer. Technical considerations.

ORL J Otorhinolaryngol Relat Spec 2008 30;70(5):292-7. Epub 2008 Oct 30.

Department of Otolaryngology/Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article
February 2009
28 Reads
3 PubMed Central Citations(source)
0.670 Impact Factor

The molecular genetics of laryngeal cancer.

Otolaryngol Clin North Am 2008 Aug;41(4):657-72, v

Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.

View Article
August 2008
13 Reads
1 PubMed Central Citation(source)
1.340 Impact Factor

Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.

Head Neck 2008 Jul;30(7):898-903

The Department of Otolaryngology-Head and Neck Surgery, Pennsylvania State Hershey Medical Center, Hershey, Pennsylvania, USA.

View Article
July 2008
11 Reads
56 PubMed Central Citations(source)
2.640 Impact Factor

Aggressive recurrent respiratory papillomatosis in a neonate.

Int J Pediatr Otorhinolaryngol 2008 Jun 18;72(6):917-20. Epub 2008 Apr 18.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

View Article
June 2008
10 Reads
1 PubMed Central Citation(source)
1.320 Impact Factor

Immunotherapy for head and neck cancer.

J Biomed Sci 2008 May 5;15(3):275-89. Epub 2008 Apr 5.

Department of Otolaryngology/Head and Neck Surgery, The Johns Hopkins Medical Institutions, 601 North Caroline Street, Baltimore, MD 21287, USA.

View Article
May 2008
11 Reads
8 PubMed Central Citations(source)
2.740 Impact Factor

Concurrent sporadic parathyroid adenoma and carcinoma.

Am J Otolaryngol 2006 Sep-Oct;27(5):346-8

Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University, School of Medicine, Baltimore, MD 21287-0910, USA.

View Article
April 2008
13 Reads
2 PubMed Central Citations(source)
1.080 Impact Factor

A retropharyngeal pseudoabscess in a patient with paroxysmal nocturnal hemoglobinuria.

Otolaryngol Head Neck Surg 2007 Oct;137(4):684-6

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0919, USA.

View Article
October 2007
13 Reads
1.720 Impact Factor

Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.

Cancer Res 2007 Jan;67(2):802-11

Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University, Gyeonggi-Do, South Korea.

View Article
January 2007
19 Reads
45 PubMed Central Citations(source)
9.330 Impact Factor

Laryngeal muscle surface receptors identified using random phage library.

Laryngoscope 2005 Nov;115(11):1930-7

Department of Otolaryngology-Head and Neck Surgery Johns Hopkins University, Baltimore, Maryland, USA.

View Article
November 2005
11 Reads
1 PubMed Central Citation(source)
2.030 Impact Factor

A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response.

J Biomed Sci 2004 Jul-Aug;11(4):493-9

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article
March 2005
13 Reads
7 PubMed Central Citations(source)
2.740 Impact Factor

Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects.

J Biomed Sci 2002 Nov-Dec;9(6 Pt 2):675-87

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.

View Article
October 2003
17 Reads
7 PubMed Central Citations(source)
2.740 Impact Factor

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.

Vaccine 2003 Sep;21(25-26):4036-42

Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institution, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

View Article
September 2003
12 Reads
50 PubMed Central Citations(source)
3.620 Impact Factor

Leiomyosarcoma of the auricle.

Otolaryngol Head Neck Surg 2003 Mar;128(3):442-4

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article
March 2003
12 Reads
1 PubMed Central Citation(source)
1.720 Impact Factor

Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.

Clin Cancer Res 2002 May;8(5):1203-9

Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.

View Article
May 2002
15 Reads
36 PubMed Central Citations(source)
8.720 Impact Factor

Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.

Cancer Epidemiol Biomarkers Prev 2002 Jan;11(1):3-6

Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.

View Article
January 2002
16 Reads
16 PubMed Central Citations(source)
4.120 Impact Factor

Top co-authors

William H Westra
William H Westra

Department of Pathology

19
Chien-fu Hung
Chien-fu Hung

The Johns Hopkins University

15
Ralph P Tufano
Ralph P Tufano

Johns Hopkins University School of Medicine

12
T-C Wu
11
Justin A Bishop
Justin A Bishop

Department of Pathology

9
John R Saunders
John R Saunders

Jr. Head and Neck Center

9
Shiwen Peng
Shiwen Peng

Department of Pathology

8
Patrick K Ha
Patrick K Ha

Johns Hopkins University School of Medicine

7
Simon R Best
Simon R Best

Johns Hopkins School of Medicine

7
Takenori Ogawa
Takenori Ogawa

Tohoku University School of Medicine

6